Drug Profile
Batroxobin - Lee's Pharmaceutical
Alternative Names: Haemocoagulase - Lee's Pharmaceutical; Slounase; Snake venom thrombin- Lee's PharmaceuticalLatest Information Update: 30 Dec 2022
Price :
$50
*
At a glance
- Originator Lee's Pharmaceutical
- Class Coagulants; Crotalid venoms; Serine endopeptidases
- Mechanism of Action Fibrinogen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Blood coagulation disorders
- Discontinued Lung disorders
Most Recent Events
- 30 Dec 2022 Discontinued - Clinical-Phase-Unknown for Lung disorders in China (Parenteral)
- 28 Jul 2020 No recent reports of development identified for clinical-Phase-Unknown development in Lung-disorders in China (Parenteral, Injection)
- 06 Jun 2017 Clinical trials in Lung disorders in China (Parenteral) (NCT03270735)